To evaluate the prognostic value of "early" and "late" Fluorine-18-Fluorodeoxyglucose ((18)F-FDG) positron emission tomography-computed tomography (PET-CT) in patients with head and neck squamous cell carcinoma (HNSCC) treated with radio-chemotherapy (RTCT).
Castaldi, P., Rufini, V., Bussu, F., Micciche', F., Dinapoli, N., Autorino, R., Lago, M., De Corso, E., Almadori, G., Galli, J., Paludetti, G., Giordano, A., Valentini, V., Can "early" and "late"18F-FDG PET-CT be used as prognostic factors for the clinical outcome of patients with locally advanced head and neck cancer treated with radio-chemotherapy?, <<RADIOTHERAPY AND ONCOLOGY>>, 2012; 103 (1): 63-68. [doi:10.1016/j.radonc.2012.03.001] [http://hdl.handle.net/10807/7209]
Can "early" and "late"18F-FDG PET-CT be used as prognostic factors for the clinical outcome of patients with locally advanced head and neck cancer treated with radio-chemotherapy?
Castaldi, Paola;Rufini, Vittoria;Bussu, Francesco;Micciche', Francesco;Dinapoli, Nicola;Autorino, Rosa;Lago, Mariaelena;De Corso, Eugenio;Almadori, Giovanni;Galli, Jacopo;Paludetti, Gaetano;Giordano, Aldo;Valentini, Viola
2012
Abstract
To evaluate the prognostic value of "early" and "late" Fluorine-18-Fluorodeoxyglucose ((18)F-FDG) positron emission tomography-computed tomography (PET-CT) in patients with head and neck squamous cell carcinoma (HNSCC) treated with radio-chemotherapy (RTCT).
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
